Literature DB >> 19426233

Sequence, structure, function, immunity: structural genomics of costimulation.

Kausik Chattopadhyay1, Eszter Lazar-Molnar, Qingrong Yan, Rotem Rubinstein, Chenyang Zhan, Vladimir Vigdorovich, Udupi A Ramagopal, Jeffrey Bonanno, Stanley G Nathenson, Steven C Almo.   

Abstract

SUMMARY: Costimulatory receptors and ligands trigger the signaling pathways that are responsible for modulating the strength, course, and duration of an immune response. High-resolution structures have provided invaluable mechanistic insights by defining the chemical and physical features underlying costimulatory receptor:ligand specificity, affinity, oligomeric state, and valency. Furthermore, these structures revealed general architectural features that are important for the integration of these interactions and their associated signaling pathways into overall cellular physiology. Recent technological advances in structural biology promise unprecedented opportunities for furthering our understanding of the structural features and mechanisms that govern costimulation. In this review, we highlight unique insights that have been revealed by structures of costimulatory molecules from the immunoglobulin and tumor necrosis factor superfamilies and describe a vision for future structural and mechanistic analysis of costimulation. This vision includes simple strategies for the selection of candidate molecules for structure determination and highlights the critical role of structure in the design of mutant costimulatory molecules for the generation of in vivo structure-function correlations in a mammalian model system. This integrated 'atoms-to-animals' paradigm provides a comprehensive approach for defining atomic and molecular mechanisms.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19426233      PMCID: PMC3001128          DOI: 10.1111/j.1600-065X.2009.00778.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  131 in total

Review 1.  Nectins and nectin-like molecules: roles in contact inhibition of cell movement and proliferation.

Authors:  Yoshimi Takai; Jun Miyoshi; Wataru Ikeda; Hisakazu Ogita
Journal:  Nat Rev Mol Cell Biol       Date:  2008-08       Impact factor: 94.444

Review 2.  New roles for TIM family members in immune regulation.

Authors:  Vijay K Kuchroo; Valerie Dardalhon; Sheng Xiao; Ana C Anderson
Journal:  Nat Rev Immunol       Date:  2008-08       Impact factor: 53.106

3.  Engagement of glucocorticoid-induced TNFR family-related receptor on effector T cells by its ligand mediates resistance to suppression by CD4+CD25+ T cells.

Authors:  Geoffrey L Stephens; Rebecca S McHugh; Matthew J Whitters; Deborah A Young; Deborah Luxenberg; Beatriz M Carreno; Mary Collins; Ethan M Shevach
Journal:  J Immunol       Date:  2004-10-15       Impact factor: 5.422

4.  Identification of Tim4 as a phosphatidylserine receptor.

Authors:  Masanori Miyanishi; Kazutoshi Tada; Masato Koike; Yasuo Uchiyama; Toshio Kitamura; Shigekazu Nagata
Journal:  Nature       Date:  2007-10-24       Impact factor: 49.962

5.  Kidney injury molecule-1 is a phosphatidylserine receptor that confers a phagocytic phenotype on epithelial cells.

Authors:  Takaharu Ichimura; Edwin J P V Asseldonk; Benjamin D Humphreys; Lakshman Gunaratnam; Jeremy S Duffield; Joseph V Bonventre
Journal:  J Clin Invest       Date:  2008-05       Impact factor: 14.808

Review 6.  The SLAM and SAP gene families control innate and adaptive immune responses.

Authors:  Silvia Calpe; Ninghai Wang; Xavier Romero; Scott B Berger; Arpad Lanyi; Pablo Engel; Cox Terhorst
Journal:  Adv Immunol       Date:  2008       Impact factor: 3.543

7.  The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells.

Authors:  Xin Yu; Kristin Harden; Lino C Gonzalez; Michelle Francesco; Eugene Chiang; Bryan Irving; Irene Tom; Sinisa Ivelja; Canio J Refino; Hilary Clark; Dan Eaton; Jane L Grogan
Journal:  Nat Immunol       Date:  2008-11-16       Impact factor: 25.606

8.  Assembly and structural properties of glucocorticoid-induced TNF receptor ligand: Implications for function.

Authors:  Kausik Chattopadhyay; Udupi A Ramagopal; Arunika Mukhopadhaya; Vladimir N Malashkevich; Teresa P Dilorenzo; Michael Brenowitz; Stanley G Nathenson; Steven C Almo
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-26       Impact factor: 11.205

9.  Crystal structure of the complex between programmed death-1 (PD-1) and its ligand PD-L2.

Authors:  Eszter Lázár-Molnár; Qingrong Yan; Erhu Cao; Udupi Ramagopal; Stanley G Nathenson; Steven C Almo
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-18       Impact factor: 11.205

10.  Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection.

Authors:  R Brad Jones; Lishomwa C Ndhlovu; Jason D Barbour; Prameet M Sheth; Aashish R Jha; Brian R Long; Jessica C Wong; Malathy Satkunarajah; Marc Schweneker; Joan M Chapman; Gabor Gyenes; Bahareh Vali; Martin D Hyrcza; Feng Yun Yue; Colin Kovacs; Aref Sassi; Mona Loutfy; Roberta Halpenny; Desmond Persad; Gerald Spotts; Frederick M Hecht; Tae-Wook Chun; Joseph M McCune; Rupert Kaul; James M Rini; Douglas F Nixon; Mario A Ostrowski
Journal:  J Exp Med       Date:  2008-11-10       Impact factor: 14.307

View more
  40 in total

1.  Computational Redesign of PD-1 Interface for PD-L1 Ligand Selectivity.

Authors:  Rojan Shrestha; Sarah C Garrett; Steven C Almo; Andras Fiser
Journal:  Structure       Date:  2019-03-28       Impact factor: 5.006

2.  Structural Basis of CD160:HVEM Recognition.

Authors:  Weifeng Liu; Sarah C Garrett; Elena V Fedorov; Udupi A Ramagopal; Scott J Garforth; Jeffrey B Bonanno; Steven C Almo
Journal:  Structure       Date:  2019-06-20       Impact factor: 5.006

3.  Advancing targeted co-stimulation with antibody-fusion proteins by introducing TNF superfamily members in a single-chain format.

Authors:  Sina Fellermeier; Nadine Beha; Jan-Erik Meyer; Sarah Ring; Stefan Bader; Roland E Kontermann; Dafne Müller
Journal:  Oncoimmunology       Date:  2016-09-27       Impact factor: 8.110

4.  Discovery of receptor-ligand interfaces in the immunoglobulin superfamily.

Authors:  Nelson Gil; Eduardo J Fajardo; Andras Fiser
Journal:  Proteins       Date:  2019-07-29

5.  Structural, mutational and biophysical studies reveal a canonical mode of molecular recognition between immune receptor TIGIT and nectin-2.

Authors:  Dibyendu Samanta; Haisu Guo; Rotem Rubinstein; Udupi A Ramagopal; Steven C Almo
Journal:  Mol Immunol       Date:  2016-12-12       Impact factor: 4.407

6.  Structural Insights into N-terminal IgV Domain of BTNL2, a T Cell Inhibitory Molecule, Suggests a Non-canonical Binding Interface for Its Putative Receptors.

Authors:  Aditya J Basak; Snigdha Maiti; Anita Hansda; Dhrubajyoti Mahata; Kheerthana Duraivelan; Shankar V Kundapura; Woonghee Lee; Gayatri Mukherjee; Soumya De; Dibyendu Samanta
Journal:  J Mol Biol       Date:  2020-10-05       Impact factor: 5.469

7.  Crystal structures of the human 4-1BB receptor bound to its ligand 4-1BBL reveal covalent receptor dimerization as a potential signaling amplifier.

Authors:  Aruna Bitra; Tzanko Doukov; Michael Croft; Dirk M Zajonc
Journal:  J Biol Chem       Date:  2018-05-02       Impact factor: 5.157

8.  Functional classification of immune regulatory proteins.

Authors:  Rotem Rubinstein; Udupi A Ramagopal; Stanley G Nathenson; Steven C Almo; Andras Fiser
Journal:  Structure       Date:  2013-04-11       Impact factor: 5.006

9.  Structure and T cell inhibition properties of B7 family member, B7-H3.

Authors:  Vladimir Vigdorovich; Udupi A Ramagopal; Eszter Lázár-Molnár; Eliezer Sylvestre; Jun Sik Lee; Kimberly A Hofmeyer; Xingxing Zang; Stanley G Nathenson; Steven C Almo
Journal:  Structure       Date:  2013-04-11       Impact factor: 5.006

Review 10.  Molecular mechanisms of T cell co-stimulation and co-inhibition.

Authors:  Lieping Chen; Dallas B Flies
Journal:  Nat Rev Immunol       Date:  2013-03-08       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.